Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 20 studies | 58% ± 15% | |
| lung | 18 studies | 57% ± 16% | |
| intestine | 13 studies | 53% ± 20% | |
| kidney | 9 studies | 49% ± 17% | |
| eye | 6 studies | 32% ± 14% | |
| bone marrow | 6 studies | 48% ± 24% | |
| lymph node | 6 studies | 55% ± 18% | |
| pancreas | 5 studies | 65% ± 27% | |
| uterus | 5 studies | 63% ± 26% | |
| liver | 5 studies | 56% ± 17% | |
| placenta | 4 studies | 62% ± 23% | |
| brain | 4 studies | 41% ± 14% | |
| prostate | 4 studies | 51% ± 9% | |
| breast | 4 studies | 59% ± 6% | |
| adrenal gland | 3 studies | 50% ± 14% | |
| esophagus | 3 studies | 56% ± 24% | |
| skin | 3 studies | 39% ± 16% | |
| thymus | 3 studies | 60% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 8283.75 | 258 / 258 | 100% | 229.45 | 230 / 230 |
| skin | 100% | 5707.05 | 1809 / 1809 | 100% | 156.28 | 472 / 472 |
| thymus | 100% | 6490.05 | 653 / 653 | 100% | 139.30 | 605 / 605 |
| uterus | 100% | 5794.18 | 170 / 170 | 100% | 151.52 | 459 / 459 |
| ovary | 100% | 4664.35 | 180 / 180 | 100% | 138.54 | 429 / 430 |
| liver | 100% | 6874.25 | 226 / 226 | 100% | 116.78 | 405 / 406 |
| esophagus | 100% | 4586.44 | 1445 / 1445 | 99% | 87.90 | 182 / 183 |
| pancreas | 100% | 16096.85 | 328 / 328 | 99% | 165.57 | 177 / 178 |
| intestine | 100% | 6116.67 | 966 / 966 | 99% | 170.59 | 524 / 527 |
| lung | 100% | 6685.91 | 578 / 578 | 99% | 177.24 | 1147 / 1155 |
| stomach | 100% | 7341.18 | 359 / 359 | 99% | 151.84 | 284 / 286 |
| prostate | 100% | 7796.87 | 245 / 245 | 99% | 225.70 | 498 / 502 |
| kidney | 100% | 5240.88 | 89 / 89 | 99% | 91.19 | 893 / 901 |
| bladder | 100% | 5527.76 | 21 / 21 | 99% | 157.45 | 498 / 504 |
| brain | 99% | 3006.19 | 2618 / 2642 | 100% | 95.11 | 703 / 705 |
| breast | 100% | 5532.99 | 459 / 459 | 99% | 144.10 | 1102 / 1118 |
| eye | 0% | 0 | 0 / 0 | 100% | 136.12 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 176.19 | 29 / 29 |
| spleen | 100% | 10509.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 129.46 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 81.29 | 1 / 1 |
| adipose | 100% | 4888.67 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6270.19 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 5707.82 | 920 / 929 | 0% | 0 | 0 / 0 |
| heart | 97% | 4343.76 | 837 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 1985.29 | 758 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0005784 | Cellular component | Sec61 translocon complex |
| GO_0070062 | Cellular component | extracellular exosome |
| Gene name | SSR4 |
| Protein name | Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta) Translocon-associated protein subunit delta (Signal sequence receptor subunit delta) |
| Synonyms | TRAPD |
| Description | FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. . |
| Accessions | ENST00000370087.5 ENST00000370086.8 ENST00000370085.3 A6NLM8 ENST00000320857.7 P51571 |